• Return to Headlines

Aimmune Therapeu: New 52-Week Low Set Today (AIMT)

By Shiri Gupta

Shares of Aimmune Therapeu (NASDAQ:AIMT) traded today at $18.67, breaking its 52-week low. So far today approximately 285,000 shares have been exchanged, as compared to an average 30-day volume of 429,000 shares.

Potential upside of 221.3% exists for Aimmune Therapeu, based on a current level of $18.81 and analysts' average consensus price target of $60.44. The stock should run into initial resistance at its 50-day moving average (MA) of $20.21 and subsequent resistance at its 200-day MA of $23.45.

Over the past year, Aimmune Therapeuhas traded in a range of $18.67 to $36.12 and are now at $18.81. Over the past week, the 200-day moving average (MA) has gone down 0.5% while the 50-day MA has remained constant.

Aimmune Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing treatments to protect children with food allergies from accidental exposure. Aimmune Therapeutics serves customers in the United States.

SmarTrend recommended that its subscribers protect gains by selling shares of Aimmune Therapeu on March 20th, 2019 by issuing a Downtrend alert when the shares were trading at $21.45. Since that call, shares of Aimmune Therapeu have fallen 7.3%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: 52 week high/lows aimmune therapeu

Ticker(s): AIMT